May 12, 2021

Huntsman Cancer Institute Names Kevin Cheney as Executive Director of Finance and Administration

Huntsman Cancer Institute announces Kevin Cheney, MBA, CPA, has been appointed executive director of finance and administration. In this role, Cheney will serve as an executive leader with responsibility for HCI’s research finances and administrative units. He will also continue to oversee budgets and financial analysis for HCI’s cancer hospital and clinical programs.

May 11, 2021

New Research Outlines a Critical Driver in an Immune Cell’s Defense against Melanoma

Researchers at Huntsman Cancer Institute have found critical new insights into how cells defend against melanoma. In a report published in Nature Communications, the team describes how an enzyme called nicotinamide phosphoribosyltransferase, or NAMPT, initiates antitumor activity. The researchers suggest that new therapies strengthening this pathway in immune cells could be the foundation for more effective treatments against melanoma.

May 10, 2021

Huntsman Cancer Institute Congratulates Faculty on Recent Academic Honors

Huntsman Cancer Institute recognizes new and renewed endowed chairs, along with the distinguished professorship of faculty. Endowed chairs play an important role in creating a partnership between donors and researchers. Distinguished professors are recognized for academic achievements and dedication to teaching.

May 06, 2021

Huntsman Cancer Institute Appoints Kola Okuyemi, MD, MPH, to Lead Equity, Diversity, and Inclusion

Huntsman Cancer Institute has named Kola Okuyemi, MD, MPH, as executive director of equity, diversity, and inclusion. Okuyemi will oversee efforts at HCI to actively counter racism and promote a culture of belonging, a key strategic priority for the cancer center. This new role expands Okuyemi’s current oversight to include equity, diversity, and inclusion across the full spectrum of the HCI mission.

May 06, 2021

Pheo Para Alliance Designates Huntsman Cancer Institute as First Center of Excellence

Huntsman Cancer Institute at the University of Utah is the first center to receive a Center of Excellence designation from Pheo Para Alliance, a patient advocacy organization dedicated to supporting those with pheochromocytoma and paraganglioma, a rare neuroendocrine tumor. Huntsman Cancer Institute serves over 250 pheo and para patients from throughout the Mountain West, including Utah and parts of Idaho, Montana, Nevada, and Wyoming.

May 06, 2021

Message from Our Nursing Director

The year 2020 was designated as the international Year of the Nurse in celebration of Florence Nightingale’s 200th birthday. And what a year it was for nursing on the local, national, and world stage. Our 500-plus nurses at Huntsman Cancer Institute have shined during an unprecedented time, showing compassion, resilience, and grit through a pandemic, social unrest and injustice, and emergency responses during an earthquake and hurricane-force winds.

May 03, 2021

Getting through Brain Cancer with the Right People around You

When David Reyes had trouble writing, he chalked it up to a nerve issue. But then came headaches so painful he ended up in the ER. David was eventually diagnosed with a medulloblastoma, a type of brain tumor. David says though brain cancer has left him unable to do certain things, he’s grateful to be alive—and to have wonderful friends and family who have supported him along the way.

Apr 29, 2021

Working to Eliminate Disparities in Genetic Counseling and Testing

Black, Latinx, and Asian populations have the lowest rates of genetic counseling and testing. These important data can help find inherited mutations that could cause the disease. Huntsman Cancer Institute works to share the importance of knowing family cancer history, create easier access to genetic counseling and testing, and educate about hereditary cancers.